1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296

Glenmark Pharma Live Share Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
In 2 Starfolio Baskets
about

Incorporated in 1977, Glenmark Pharmaceuticals is engaged in the business of development, manufacturing and marketing of pharmaceutical products. The company products in key therapeutic areas includes dermatology, respiratory, oncology, cardiology, d...

Read More
2027.20 -8.00 (-0.39%)
58.93% Gain from 52W Low
33,696
NSE+BSE Volume

NSE 01 Jan, 2026 10:34 AM (IST)

Watchlist

Portfolio

Alert
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
High Financial Strength
- / 100
Valuation Score
Mid Valuation
- / 100
Momentum Score
Technically Moderately Bullish
63.9 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM
Analyst Price Target
2,112
1Yr Price target upside is 4%
12 analysts

24

S

8

W

6

O

1

T

SWOT Analysis

Glenmark Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
Is Glenmark Pharmaceuticals Ltd. worth buying?
580 Votes:
Buy 79.48%
Sell 13.62%
Hold 6.9%
BUY
SELL
HOLD